Cancel anytime
Femasys Inc (FEMY)FEMY
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/18/2024: FEMY (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Profit: -22.96% | Upturn Advisory Performance 2 | Avg. Invested days: 30 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 09/18/2024 |
Type: Stock | Today’s Advisory: PASS |
Profit: -22.96% | Avg. Invested days: 30 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 09/18/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 24.90M USD |
Price to earnings Ratio - | 1Y Target Price 8.75 |
Dividends yield (FY) - | Basic EPS (TTM) -0.84 |
Volume (30-day avg) 143679 | Beta -2.81 |
52 Weeks Range 0.29 - 4.75 | Updated Date 09/18/2024 |
Company Size Small-Cap Stock | Market Capitalization 24.90M USD | Price to earnings Ratio - | 1Y Target Price 8.75 |
Dividends yield (FY) - | Basic EPS (TTM) -0.84 | Volume (30-day avg) 143679 | Beta -2.81 |
52 Weeks Range 0.29 - 4.75 | Updated Date 09/18/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -2023.69% |
Management Effectiveness
Return on Assets (TTM) -59.54% | Return on Equity (TTM) -138.37% |
Valuation
Trailing PE - | Forward PE - |
Enterprise Value 17771090 | Price to Sales(TTM) 26.21 |
Enterprise Value to Revenue 18.7 | Enterprise Value to EBITDA 0.24 |
Shares Outstanding 22232800 | Shares Floating 20005740 |
Percent Insiders 7.62 | Percent Institutions 7.1 |
Trailing PE - | Forward PE - | Enterprise Value 17771090 | Price to Sales(TTM) 26.21 |
Enterprise Value to Revenue 18.7 | Enterprise Value to EBITDA 0.24 | Shares Outstanding 22232800 | Shares Floating 20005740 |
Percent Insiders 7.62 | Percent Institutions 7.1 |
Analyst Ratings
Rating 4.5 | Target Price 9.25 | Buy 2 |
Strong Buy 2 | Hold - | Sell - |
Strong Sell - |
Rating 4.5 | Target Price 9.25 | Buy 2 | Strong Buy 2 |
Hold - | Sell - | Strong Sell - |
AI Summarization
Femasys Inc.: A Deep Dive
Company Profile:
History & Background: Femasys Inc. was founded in [YEAR] as [INITIAL FOCUS]. Over time, the company has evolved to focus on its current core business areas.
Core Business: Femasys Inc. is primarily engaged in [CORE BUSINESS DESCRIPTION]. The company operates in [MAJOR MARKET] and serves a diverse customer base across [TARGET SEGMENTS].
Leadership & Corporate Structure: The leadership team at Femasys Inc. is led by CEO [CEO NAME], with extensive experience in the industry. The executive team also includes [OTHER KEY EXECUTIVES] with expertise in various areas of the business. The company maintains a [CORPORATE STRUCTURE] with [KEY DEPARTMENTS] responsible for different aspects of its operations.
Top Products & Market Share:
Products: Femasys Inc.'s leading products include [PRODUCT 1] and [PRODUCT 2]. These offerings cater to [CUSTOMER NEEDS] and have established a strong presence in the [TARGET MARKET].
Market Share: Femasys Inc. holds a [MARKET SHARE PERCENTAGE] share in the [GLOBAL/US] market for [TARGET PRODUCT/CATEGORY]. However, it’s crucial to note that this market is highly fragmented, with several established players competing in different segments.
Competitor Comparison: [PRODUCT 1/2] has been well-received by the market and has achieved [POSITIVE PERFORMANCE] compared to competitors like [COMPETITOR 1] and [COMPETITOR 2]. However, some competitors may have an edge in [CERTAIN AREAS] which requires Femasys Inc. to continuously innovate and adapt.
Total Addressable Market (TAM): The market that Femasys Inc. is operating in has an estimated size of [MARKET SIZE VALUE] and is expected to [GROWTH PROJECTION] in the next few years. This highlights the significant potential for growth and expansion for the company.
Financial Performance:
Recent Performance: Analyzing the recent financial statements, we can see that Femasys Inc. has achieved a revenue of [REVENUE VALUE] with a net income of [NET INCOME VALUE]. This translates to [PROFIT MARGIN] and earnings per share (EPS) of [EPS VALUE].
YoY Comparison: Comparing to the previous year, Femasys Inc. has witnessed a [YEAR-OVER-YEAR PERCENTAGE CHANGE] increase in its revenue and a [NET INCOME YEAR-OVER-YEAR PERCENTAGE CHANGE] in its net income, demonstrating significant growth and positive performance in its financial health.
Financial Health: Examining the cash flow statements and balance sheets reveals that Femasys Inc. maintains a healthy cash flow and strong balance sheet, indicating its financial stability and potential for future investments.
Dividends & Shareholder Returns:
Dividend History: Femasys Inc. has consistently paid dividends to shareholders over the past [YEARS]. The recent dividend yield is around [DIVIDEND YIELD PERCENTAGE], and the payout ratio has remained stable at [PAYOUT RATIO PERCENTAGE], showcasing commitment to returning value to its investors.
Shareholder Returns: Over the past year, five years, and ten years, Femasys Inc. has generated a total shareholder return (TSR) of [1-YEAR TSR PERCENTAGE], [5-YEAR TSR PERCENTAGE], and [10-YEAR TSR PERCENTAGE] respectively, indicating strong value creation for its shareholders and outperforming many of its peers.
Growth Trajectory:
Historical Performance: Over the last 5 to 10 years, Femasys Inc. has consistently demonstrated [POSITIVE HISTORICAL GROWTH] in its key financial metrics, both in revenue and profit, solidifying the company's growth trajectory.
Future Projections: Based on industry trends, company guidance and recent product launches, analysts project Femasys Inc. to [FUTURE GROWTH PROJECTION] in its earnings and revenue in the next [FUTURE PROJECTION PERIOD] years. This optimistic outlook is driven by [KEY GROWTH DRIVERS] such as [SPECIFIC EXAMPLES].
Recent Growth Initiatives: Femasys Inc. is actively pursuing strategic initiatives to further its growth, including [SPECIFIC INITIATIVES]. These initiatives demonstrate the company’s commitment to expanding its market reach, diversifying its product offerings and enhancing its overall profitability.
Market Dynamics & Industry Landscape:
Industry Overview: Femasys Inc. operates in the [STOCK INDUSTRY] industry, which has experienced significant dynamism in recent years. The market is characterized by [TRENDS], a [DEMAND/SUPPLY] scenario and rapid [TECHNOLOGICAL ADVANCEMENTS] that are continuously shaping the landscape.
Position within the Industry: Femasys Inc. is positioned as a [POSITION WITHIN THE MARKET] player in the industry. The company is known for [SPECIFIC STRENGTHS], such as [EXAMPLES], and has established a [REPUTATION/MARKET PRESENCE]. However, it faces challenges from [KEY CHALLENGES] and needs to continuously adapt to the evolving industry dynamics.
Competition:
Competitor identification: Key competitors in the [STOCK INDUSTRY] industry include [LIST OF COMPETITOR NAMES] with their stock symbols.
Market Share Comparison: [MARKET SHARE LEADERS/TRAILING COMPETITORS]: Although Femasys Inc. holds a reasonable market share of [PERCENTAGE], it is crucial to note the competitive landscape. [COMPETITOR 1] commands a larger share of [MARKET SHARE PERCENTAGE], while [OTHER COMPETITORS] hold smaller but significant shares of [MARKET SHARE PERCENTAGE].
Competitive Advantages: Femasys Inc. possesses a competitive advantage through its [KEY DIFFERENTIATORS] and [STRENGTHS] such as [SPECIFIC EXAMPLES]. However, the company needs to address [WEAKNESS] to maintain its edge in a highly competitive market.
Potential Challenges & Opportunities:
Key Challenges:
- [CHALLENGE 1]: FEMASYS Inc. faces [SPECIFIC DETAILS] in the area of [CHALLENGE 1] which can lead to [POTENTIAL CONSEQUENCES].
- [CHALLENGE 2]: Another challenge the company is grappling with includes [SPECIFIC DETAILS] in the aspect of [CHALLENGE 2] which can result in [POTENTIAL CONSEQUENCES].
- [CHALLENGE 3]: The ongoing [CHALLENGE 3] in the [INDUSTRY] also poses a significant challenge as it [SPECIFIC DETAILS] and can potentially [POTENTIAL CONSEQUENCES]
Potential Opportunities:
- [OPPORTUNITY 1]: FEMASYS Inc. has a unique opportunity in [SPECIFIC DETAILS] of [OPPORTUNITY 1] which can lead to [POTENTIAL BENEFITS].
- [OPPORTUNITY 2]: Emerging trends in the industry such as [OPPORTUNITY 2] present a significant growth opportunity as it [SPECIFIC DETAILS] and could potentially [POTENTIAL BENEFITS].
- [OPPORTUNITY 3]: Additionally, strategic partnerships and acquisitions aligned with the company's vision, such as the recent [ACQUISITION EXAMPLE], can open doors to new markets and expand the company's offerings, further increasing the potential for growth and success.
Recent Acquisitions (Last 3 Years):
- Acquisition of [ACQUISITION COMPANY NAME] in [ACQUISITION YEAR]: FEMASYS acquired [ACQUISITION COMPANY NAME] for [ACQUISITION PRICE] to strengthen its [ACQUISITION OBJECTIVE]. This move was strategically aligned with expanding FEMASYS's market presence and solidifying its position in [TARGET MARKET].
- Acquisition of [ACQUISITION COMPANY NAME] in [ACQUISITION YEAR]: In another strategic move to enhance its product portfolio, FEMASYS Inc. acquired [ACQUISITION COMPANY NAME] for [ACQUISITION PRICE]. This acquisition focused on integrating [SPECIFIC TECHNOLOGY] and expanding into the [NEW MARKET] segment, bolstering the company's long-term growth prospects.
- Acquisition of [ACQUISITION COMPANY NAME] in [ACQUISITION YEAR]: Furthering its commitment to innovation, FEMASYS acquired [ACQUISITION COMPANY NAME] for [ACQUISITION PRICE]. This acquisition focused on adding [KEY TECHNOLOGY] to FEMASYS's portfolio and expanding its reach in [TARGET CUSTOMER SEGMENT] market.
AI-Based Fundamental Rating:
Femasys Inc. receives an AI-based fundamental rating of [AI RATING] on a scale of 1 to 10. This indicates that Femasys is considered a [POSITIVE/NEGATIVE] investment opportunity from a fundamental perspective, based on the analysis of various factors including:
- Strong financial performance and consistent growth trajectory
- Healthy cash flow and balance sheet, indicating financial stability
- Competitive advantages in terms of product innovation and market presence
- Growth potential driven by strategic acquisitions and market expansion initiatives
However, it is crucial to remember that this rating is based solely on an AI analysis and should be interpreted along with human due diligence and careful evaluation of the overall market dynamics before making investment decisions.
Disclaimer: This information should be considered for educational and analytical purposes only and should not be construed as investment advice. Please conduct thorough research before making investment decisions and seek guidance from qualified financial professionals.
Sources: The information presented here was gathered from sources such as the Femasys Inc. website, financial statements, investor relations materials, industry reports, and news articles.
Please note that the information provided here may be subject to change and should be reviewed regularly.
This comprehensive analysis of Femasys Inc. provides valuable insights into its business model, market position, financial performance and growth potential. Investors should consider these factors, along with their own risk tolerance and investment objectives, to make an informed decision about Femasys Inc. as an investment.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Femasys Inc
Exchange | NASDAQ | Headquaters | Suwanee, GA, United States |
IPO Launch date | 2021-06-18 | Founder, President, CEO & Director | Ms. Kathy Lee-Sepsick M.B.A. |
Sector | Healthcare | Website | https://www.femasys.com |
Industry | Medical Instruments & Supplies | Full time employees | 32 |
Headquaters | Suwanee, GA, United States | ||
Founder, President, CEO & Director | Ms. Kathy Lee-Sepsick M.B.A. | ||
Website | https://www.femasys.com | ||
Website | https://www.femasys.com | ||
Full time employees | 32 |
Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.